Author reply: phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. [electronic resource]

By:

Kleefstra, Nanne

Contributor(s):

Houweling, Sebastiaan T
Groenier, Klaas H
Bilo, Henk J G

Producer: 20081124Description: 1623-4 p. digitalISSN:

1532-8600

Subject(s):

Chromium -- administration & dosage
Diabetes Mellitus, Type 2 -- drug therapy
Humans
Phenotype

Online resources:

Available from publisher's website

In: Metabolism: clinical and experimental vol. 57

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Comment; Letter

There are no comments on this title.

Browse results Close

Back to results

1 Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.
by Vanderwall, Arden G
2 Targeting the β2-integrin LFA-1, reduces adverse neuroimmune actions in neuropathic susceptibility caused by prenatal alcohol exposure.
by Sanchez, Joshua J
3 LFA-1 antagonist (BIRT377) similarly reverses peripheral neuropathic pain in male and female mice with underlying sex divergent peripheral immune proinflammatory phenotypes.
by Noor, Shahani
4 [Ophthalmology, history and humanities].
by Santos-Bueso, E
5 The LFA-1 antagonist BIRT377 reverses neuropathic pain in prenatal alcohol-exposed female rats via actions on peripheral and central neuroimmune function in discrete pain-relevant tissue regions.
by Noor, Shahani

Author reply: phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.

APA

Kleefstra N., Houweling S. T., Groenier K. H. & Bilo H. J. G. (20081124). Author reply: phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. : Metabolism: clinical and experimental.

Chicago

Kleefstra Nanne, Houweling Sebastiaan T, Groenier Klaas H and Bilo Henk J G. 20081124. Author reply: phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. : Metabolism: clinical and experimental.

Harvard

Kleefstra N., Houweling S. T., Groenier K. H. and Bilo H. J. G. (20081124). Author reply: phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. : Metabolism: clinical and experimental.

MLA

Kleefstra Nanne, Houweling Sebastiaan T, Groenier Klaas H and Bilo Henk J G. Author reply: phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. : Metabolism: clinical and experimental. 20081124.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC